Want to join the conversation?
Human whole-genome sequencing services provider $ILMN closed two acquisitions in Jan. 2016 consisting of $18MM in upfront cash payments, equity instruments and certain contingent consideration provisions. The company believes it could total up to approx. $49MM upon the achievement of defined milestones.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.